ShengJin Fan

Dr. ShengJin Fan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2022 in Bioengineered
Verified
Journal Article
Open access
YLYabo Liu
Yabo Liu
HLHuibo Li
Huibo Li
YZYanqiu Zhao
Yanqiu Zhao
DLDandan Li
Dandan Li
QZQian Zhang
Qian Zhang
SFShengJin Fan
ShengJin Fan
Long non-coding RNAs (LncRNAs) exert important regulatory roles in chronic myeloid leukemia (CML). In this study, we aimed to investigate the potential role and molecular mechanism of lncRNA ADORA2A antisense RNA 1 (ADORA2A-AS1) in CML. We found that the expression of ADORA2A-AS1 was upregulated in CML. Further, knockdown of ADORA2A-AS1 inhibited the proliferation, induced apoptosis, arrested cell cycle, and enhanced imatinib sensitivity in CML cells. Besides, ADORA2A-AS1 promoted the expression of transforming growth factor-beta receptor 1 (TGFBR1) and ATP binding cassette subfamily C member 2 (ABCC2) via sponging miR-665, thereby exerting a tumor-promoting activity. Collectively, our results confirmed the oncogenic effect of ADORA2A-AS1 in CML, indicating that ADORA2A-AS1 is a promosing therapeutic target for CML. GRAPHICAL ABSTRACT

16 October 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
JSJingyu Song
Jingyu Song
HLHuiBo Li
HuiBo Li
SFShengJin Fan
ShengJin Fan
SET-CAN/NUP214 fusion is a recurrent event commonly observed in adult male patients diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) and has occasionally been reported in other diseases such as acute myeloid leukemia (AML), myeloid sarcoma (MS), acute undifferentiated leukemia (AUL), chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). This fusion gene is derived from chromosome del(9)(q34.11;q34.13) or t(9;9)(q34;q34) and may have an inhibitory effect on primitive progenitor differentiation. The prognosis of the reported patients is varied, with these patients often show resistance to chemotherapy regimens that include high doses of glucocorticoids. The optional treatment has not been determined, more cases need to be accumulated and evaluated. The scope of this review is to summarize the general features and prognostic significance in leukemia associated with the SET-CAN/NUP214 fusion gene and to discuss the methods of detection and treatment, aiming at providing some useful references for relevant researchers in the field of blood tumor.

1 August 2022 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
YLYabo Liu
Yabo Liu
HLHuibo Li
Huibo Li
YZYanqiu Zhao
Yanqiu Zhao
DLDandan Li
Dandan Li
QZQian Zhang
Qian Zhang
SFShengJin Fan
ShengJin Fan
The four and a half LIM domains 1 (FHL1) is considered to play important roles in tumors. This study aims to investigate the role and precise mechanisms of FHL1 in acute myeloid leukemia (AML). Here, we found that FHL1 was highly expressed in AML. CCK8, flow cytometry, and Western blot analysis of cell cycle-related proteins showed that overexpression of FHL1 promoted proliferation and accelerated cell cycle progression in HL-60 cells. Conversely, knockdown of FHL1 inhibited the proliferation and induced cell cycle arrest in KG-1 cells. Furthermore, knockdown of FHL1 promoted cell differentiation, while overexpression of FHL1 restrained all-trans retinoic acid induced cell differentiation in HL-60 cells, revealed by Wright–Giemsa staining and cell surface antigen analysis. Moreover, in vivo experiments revealed that depletion of FHL1 inhibited tumor growth and led to increased levels of CD11b and CD14. Here, we first identify an unexpected and important role of FHL1 that contributes to the AML progression, indicating that FHL1 may be a potential therapeutic target for AML.

3 September 2024 in Transplant Immunology
Verified
Journal Article
Closed access
JSJingyu Song
Jingyu Song
JLJie Liu
Jie Liu
DGDan Guo
Dan Guo
HLHuiBo Li
HuiBo Li
SFShengJin Fan
ShengJin Fan


19 September 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
HLHuibo Li
Huibo Li
JHJinxiao Hou
Jinxiao Hou
YFYueyue Fu
Yueyue Fu
YZYanqiu Zhao
Yanqiu Zhao
JLJie Liu
Jie Liu
SFShengJin Fan
ShengJin Fan